Reported about 11 hours ago
Morgan Stanley has initiated equal weight coverage on Novo Nordisk, highlighting potential growth in the global obesity market. Despite a slight drop in Novo's stock, the firm sees opportunities, although concerns about pricing and negotiations with the government could impact market expectations for Novo and its rivals, including Eli Lilly.
Source: YAHOO